NAICS 541714

Research and Development in Biotechnology (except Nanobiotechnology) contracts

Open federal opportunities classified under NAICS 541714.

What next? Found opportunities you can win? Start free in GovCon to bid with AI.

Get email alerts for this search

New contracts matching these filters, straight to your inbox. Free — no account needed.

We’ll only email you about matching contracts. Want instant alerts, saved searches and AI proposals? Start free in the app →

Set-asides used in this sector

Small Business8(a)HUBZoneSDVOSBWOSB

About NAICS 541714

Biotechnology R&D — recombinant DNA, cell biology, immunology, and related research. Heavily used by NIH, BARDA, and DoD medical research commands for funded biotech programmes.

Typical award value: $500K – $100M+ per award.

Full NAICS 541714 guide →

Research and Development in Biotechnology (except Nanobiotechnology) contracts

About NAICS 541714

Research and Development in Biotechnology (except Nanobiotechnology) contracts

About NAICS 541714

TECHNOLOGY LICENSING OPPORTUNITY: Peptoid-Based Chelating Ligands for Selective Metal Chelation

Systematic Targeting Of MicroPlastics (STOMP)

Virtual-Integrated Twin for Autonomous Lifesaving (VITAL)

Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)

NAWCWD Broad Agency Announcement

Biological Technologies

BARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003)